Agresta Samuel 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed Oct 16, 2019
Insider Transaction Report
Form 4
Agresta Samuel
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-10-16+60,000→ 60,000 totalExercise: $1.14Exp: 2030-10-16→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/8th of the shares on December 31, 2019 and as to 1/8th of the shares at the end of each calendar quarter thereafter, provided that the holder continues to serve as a director of the Issuer.